Health Cor Management, L.P. Zymeworks Inc. Transaction History

Health Cor Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $13.5 Million - $19 Million	-345,550 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $10.1 Million - $16.1 Million	345,550 New	345,550 $16.1 Million
Q2 2020 Aug 14, 2020	SELL	$33.67 - $40.0 $14 Million - $16.7 Million	-416,700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $10.1 Million - $20.8 Million	416,700 New	416,700 $14.8 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.